Sertraline polymorph
US5248699A · kind A · utility
45Cited by
2References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 13, 1992 |
| Grant date | Sep 28, 1993 |
| Priority date | — |
| Expiry date | Aug 13, 2012 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2602/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to a novel crystalline polymorphic form of sertraline hydrochloride, (1S-cis)-4-(3,4-dichlorophenyl)-1,2,3,4 -tetrahydro-N-methyl-1-naphthalenamine hydrochloride, and to a method for preparing it.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.